SCHEMBL2561657

SCHEMBL2561657

CN1Cc2cc(C3(Cl)CC=C(c4cccc(F)c4Cl)CC3)ccc2-n2cnnc2C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559625 0.86 CYP11B2 (0.32) CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL2561790 0.86 CYP11B2 (0.32) CYP11B1CYP11B2
SCHEMBL2556595 0.85 CYP11B2 (0.32) CYP11B2HSD11B1
SCHEMBL2563129 0.73 TRPV1 (0.34) CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL2551927 0.73 OPRK1 (0.31) HSD11B1
SCHEMBL2563008 0.73 AVPR1A (0.36) CYP11B1CYP11B2
SCHEMBL2472145 0.72 AVPR2 (0.34)
Hydrochloric Acid SCHEMBL2559948 0.72 APP (0.31)
SCHEMBL2564173 0.72 AVPR2 (0.31) CYP11B2
SCHEMBL2574373 0.71 CYP11B2 (0.34) CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP claimed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO claimed
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed